Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase
- PMID: 2840663
- PMCID: PMC281780
- DOI: 10.1073/pnas.85.15.5478
Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase
Abstract
By using oligonucleotide-directed mutagenesis, we have produced a point mutation (guanine to adenine) at nucleotide 388 of the gene for human beta-adrenergic receptor (beta AR) that results in a substitution of asparagine for the highly conserved aspartic acid at position 130 in the putative third transmembrane domain of the human beta AR ([Asn130]beta AR). We have examined the functional significance of this mutation in B-82 cells continuously expressing the mutant [Asn130]beta AR. The mutant [Asn130]beta AR displayed normal antagonist binding but unusually high-affinity agonist binding (5- to 10-fold higher than wild-type beta AR), consistent with a single class of high-affinity binding sites. The mutant beta AR displayed guanine nucleotide-sensitive changes in agonist affinity (3- to 5-fold shift) implying an interaction between the beta AR and the stimulatory guanine nucleotide-binding regulatory protein; however, the ability of guanine nucleotides to alter agonist affinity was attenuated. Addition of saturating concentrations of isoproterenol to cell cultures expressing mutant [Asn130]-beta ARs had no effect on intracellular levels of cAMP, indicating that the mutant beta AR is unable to affect stimulation of adenylate cyclase. These results indicate that substitution of the aspartic acid with asparagine at residue 130 of the human beta AR dissociates the well-characterized guanine nucleotide effects on agonist affinity from those on activation of the stimulatory guanine nucleotide-binding regulatory protein and adenylate cyclase and suggests the existence of two distinct counterions for the amine portion of catecholamines that are associated with high- and low-affinity agonist binding states of beta AR.
Similar articles
-
Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation.J Biol Chem. 1988 Mar 25;263(9):4052-5. J Biol Chem. 1988. PMID: 2831218
-
Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase.Mech Ageing Dev. 1982 Jun;19(2):127-39. doi: 10.1016/0047-6374(82)90004-5. Mech Ageing Dev. 1982. PMID: 6287123
-
Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.Mol Pharmacol. 1991 Aug;40(2):168-79. Mol Pharmacol. 1991. PMID: 1678850
-
Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte.Adv Cyclic Nucleotide Res. 1975;5:117-32. Adv Cyclic Nucleotide Res. 1975. PMID: 165661 Review.
-
Advances on beta-adrenergic receptors. Molecular structure and functional regulation.Am J Hypertens. 1989 Nov;2(11 Pt 2):252S-256S. doi: 10.1093/ajh/2.11.252s. Am J Hypertens. 1989. PMID: 2554943 Review.
Cited by
-
Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster.J Neurosci. 1996 Jun 15;16(12):3925-33. doi: 10.1523/JNEUROSCI.16-12-03925.1996. J Neurosci. 1996. PMID: 8656286 Free PMC article.
-
Genetic fine-structural analysis of the Saccharomyces cerevisiae alpha-pheromone receptor.Cell Regul. 1991 Jun;2(6):439-52. doi: 10.1091/mbc.2.6.439. Cell Regul. 1991. PMID: 1653030 Free PMC article.
-
Drugs and receptors. An overview of the current state of knowledge.Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003. Drugs. 1990. PMID: 2292230 Review.
-
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.J Virol. 1997 Sep;71(9):6305-14. doi: 10.1128/JVI.71.9.6305-6314.1997. J Virol. 1997. PMID: 9261347 Free PMC article.
-
Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.Endocrinology. 2012 Jun;153(6):2747-55. doi: 10.1210/en.2011-1662. Epub 2012 Apr 11. Endocrinology. 2012. PMID: 22495673 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials